Make Sure You Stick With Cardinal Health, Inc. (CAH). It’s Bull Time Again

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Cardinal Health Board of Directors Approves Quarterly Dividend.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Cardinal Health, Inc. is listed on the NYSE in the Healthcare sector while operating in the Medical Distribution industry. The current market capitalization of Cardinal Health, Inc. is $25.63B. A total of 1.57 million shares were traded on the day, compared to an average of 2.14M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CAH has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 32 BUYs and 23 SELLs from insiders. Insiders purchased 299,828 shares during that period but sold 241,997.

In the most recent transaction, WEITZMAN DEBORAH sold 36,642 shares of CAH for 106.31 per share on Nov 27. After the transaction, the CEO, Pharmaceutical Segment now owns 35,202 company shares. In a previous transaction on Aug 28, WEITZMAN DEBORAH sold 6,712 shares at 89.81 per share. CAH shares that CEO, Pharmaceutical Segment owns now total 44,202.

Among the insiders who sold shares, Scherer Mary C. disposed of 20,695 shares on Aug 18 at a per-share price of $86.27. This resulted in the Chief Accounting Officer holding 10,649 shares of CAH after the transaction. In another insider transaction, Mason Stephen M sold 37,500 shares at $87.32 per share on Aug 17. Company shares held by the CEO, Medical Segment now total 37,355.

Dividend

The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Cardinal Health, Inc. pays an annual dividend of $2.00, resulting in a dividend yield of 1.90%, and it has a price to earnings (P/E) ratio of 41.48. CAH’s most recent ex-dividend date was 3/28/2024 when it declared a $0.5006 quarterly dividend that was paid in cash on 4/15/2024. Previously, the company paid the dividend on 1/15/2024 with an ex-dividend date of 12/29/2023. The CAH stock dividend was $0.5006 per share in cash.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CAH in the last 3 months, the mean price target is $114.33 with high estimates of $133.00 and low estimates of $96.00. In terms of 52-week highs and lows, CAH has a high of $111.40 and a low of $68.53.

As of this writing, CAH has an earnings estimate of $1.96 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $2.02 per share and a lower estimate of $1.9. The company reported an EPS of $1.73 in the last quarter, which was 23.60% higher than expectations of $1.4.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CAH’s latest balance sheet shows that the firm has $4.72B in Cash & Short Term Investments as of fiscal 2022. There were $5.32B in debt and $30.55B in liabilities at the time. Its Book Value Per Share was -$14.14, while its Total Shareholder’s Equity was -$706.00M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CAH is Buy with a score of 3.50.

Most Popular

Related Posts